Cargando…

Design, Synthesis, and Biological Evaluation of HDAC Degraders with CRBN E3 Ligase Ligands

Histone deacetylases (HDACs) play important roles in cell growth, cell differentiation, cell apoptosis, and many other cellular processes. The inhibition of different classes of HDACs has been shown to be closely related to the therapy of cancers and other diseases. In this study, a series of novel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Yingxin, Sun, Danwen, Xiao, Donghuai, Shao, Yingying, Su, Mingbo, Zhou, Yubo, Li, Jia, Zhu, Shulei, Lu, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658794/ https://www.ncbi.nlm.nih.gov/pubmed/34885822 http://dx.doi.org/10.3390/molecules26237241

Ejemplares similares

Regulation of AMPK Activity by CRBN Is Independent of the Thalidomide-CRL4(CRBN) Protein Degradation Axis
por: Yang, Seung-Joo, et al.
Publicado: (2021)

Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide
por: Fischer, Eric S., et al.
Publicado: (2014)

CRL4(CRBN) E3 Ligase Complex as a Therapeutic Target in Multiple Myeloma
por: Barankiewicz, Joanna, et al.
Publicado: (2022)

Proteasomal Degradation of Zn-Dependent Hdacs: The E3-Ligases Implicated and the Designed Protacs That Enable Degradation
por: Márquez-Cantudo, Laura, et al.
Publicado: (2021)

Thalidomide Inhibits Human iPSC Mesendoderm Differentiation by Modulating CRBN-dependent Degradation of SALL4
por: Belair, David G., et al.
Publicado: (2020)

Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4(CRBN)
por: Gandhi, Anita K, et al.
Publicado: (2014)

The Design and Synthesis of a New Class of RTK/HDAC Dual-Targeted Inhibitors
por: Zhang, Xuan, et al.
Publicado: (2013)

pSILAC mass spectrometry reveals ZFP91 as IMiD-dependent substrate of the CRL4(CRBN) ubiquitin ligase
por: An, Jian, et al.
Publicado: (2017)

Discovery of E3 Ligase Ligands for Target Protein Degradation
por: Lee, Jaeseok, et al.
Publicado: (2022)

MDM2 E3 ligase-mediated ubiquitination and degradation of HDAC1 in vascular calcification
por: Kwon, Duk-Hwa, et al.
Publicado: (2016)

CUL4-DDB1-CRBN E3 Ubiquitin Ligase Regulates Proteostasis of ClC-2 Chloride Channels: Implication for Aldosteronism and Leukodystrophy
por: Fu, Ssu-Ju, et al.
Publicado: (2020)

Cullin 3(SPOP) ubiquitin E3 ligase promotes the poly-ubiquitination and degradation of HDAC6
por: Tan, Yuyong, et al.
Publicado: (2017)

The ubiquitin ligase E6AP facilitates HDAC6-mediated deacetylation and degradation of tumor suppressors
por: Zhang, Yanan, et al.
Publicado: (2020)

PLZF and its fusion proteins are pomalidomide-dependent CRBN neosubstrates
por: Shimizu, Nobuyuki, et al.
Publicado: (2021)

Iberdomide (CC-220) is a potent cereblon E3 ligase modulator with antitumor and immunostimulatory activities in lenalidomide- and pomalidomide-resistant multiple myeloma cells with dysregulated CRBN
por: Bjorklund, Chad C., et al.
Publicado: (2019)

Crbn modulates calcium influx by regulating Orai1 during efferocytosis
por: Moon, Hyunji, et al.
Publicado: (2020)

De-Novo Design of Cereblon (CRBN) Effectors Guided by Natural Hydrolysis Products of Thalidomide Derivatives
por: Heim, Christopher, et al.
Publicado: (2019)

The Relationship Between the Expression of CRBN in Peripheral Blood and the Severity and Prognosis of Adult Sepsis
por: Kuang, Zhiming, et al.
Publicado: (2023)

PIWIL2 suppresses Siah2-mediated degradation of HDAC3 and facilitates CK2α-mediated HDAC3 phosphorylation
por: Zhang, Yingying, et al.
Publicado: (2018)

A Cereblon Modulator CC-885 Induces CRBN- and p97-Dependent PLK1 Degradation and Synergizes with Volasertib to Suppress Lung Cancer
por: Li, Lifeng, et al.
Publicado: (2020)

Rate of CRL4(CRBN) substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4
por: Bjorklund, C C, et al.
Publicado: (2015)

Hydroxamic Acids Immobilized on Resins (HAIRs): Synthesis of Dual‐Targeting HDAC Inhibitors and HDAC Degraders (PROTACs)
por: Sinatra, Laura, et al.
Publicado: (2020)

Mutations in CRBN and other cereblon pathway genes are infrequently associated with acquired resistance to immunomodulatory drugs
por: Jones, J. R., et al.
Publicado: (2021)

Gluconeogenic signals regulate hepcidin gene expression via a CRBN-KLF15 axis
por: Jo, Jeong-Rang, et al.
Publicado: (2021)

Thalidomide Attenuates Mast Cell Activation by Upregulating SHP-1 Signaling and Interfering with the Action of CRBN
por: Chang, Hyeun-Wook, et al.
Publicado: (2023)

FBXW7 E3 ubiquitin ligase: degrading, not degrading, or being degraded
por: Lan, Huiyin, et al.
Publicado: (2019)

Design, Synthesis and Biological Evaluation of New HDAC1 and HDAC2 Inhibitors Endowed with Ligustrazine as a Novel Cap Moiety
por: Al-Sanea, Mohammad M, et al.
Publicado: (2020)

E3 ligase ligand optimization of Clinical PROTACs
por: Jiang, Hanrui, et al.
Publicado: (2023)

Genome-wide screening reveals a role for subcellular localization of CRBN in the anti-myeloma activity of pomalidomide
por: Tateno, Shumpei, et al.
Publicado: (2020)

Comparative Genomics Identifies Putative Interspecies Mechanisms Underlying Crbn-Sall4-Linked Thalidomide Embryopathy
por: Kowalski, Thayne Woycinck, et al.
Publicado: (2021)

Discovery of small molecule ligands for the von Hippel-Lindau (VHL) E3 ligase and their use as inhibitors and PROTAC degraders
por: Diehl, Claudia J., et al.
Publicado: (2022)

Design, Synthesis and Biological Evaluation of Novel Osimertinib-Based HDAC and EGFR Dual Inhibitors
por: Dong, Hang, et al.
Publicado: (2019)

The E3 ligase Poe promotes Pericentrin degradation
por: Galletta, Brian J., et al.
Publicado: (2023)

CRBN Is a Negative Regulator of Bactericidal Activity and Autophagy Activation Through Inhibiting the Ubiquitination of ECSIT and BECN1
por: Kim, Mi-Jeong, et al.
Publicado: (2019)

The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myeloma
por: Heider, Michael, et al.
Publicado: (2021)

CRBN is downregulated in lung cancer and negatively regulates TLR2, 4 and 7 stimulation in lung cancer cells
por: Kim, Mi‐Jeong, et al.
Publicado: (2022)

Structure‐Based Design, Synthesis, and Biological Evaluation of Triazole‐Based smHDAC8 Inhibitors
por: Kalinin, Dmitrii V., et al.
Publicado: (2020)

Antibody targeting of E3 ubiquitin ligases for receptor degradation
por: Marei, Hadir, et al.
Publicado: (2022)

Metabolism, HDACs, and HDAC Inhibitors: A Systems Biology Perspective
por: King, Jacob, et al.
Publicado: (2021)

E3 Ligases Meet Their Match: Fragment-Based Approaches to Discover New E3 Ligands and to Unravel E3 Biology
por: Michaelides, Iacovos N., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_be03dedbe9acu2sciqhvh75isg